ArticleEuropean heart journal. Case reports2020

Upfront triple oral combination therapy including selexipag in a high-risk patient with idiopathic pulmonary arterial hypertension: a case report.

Serena Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.